Signals, Powered By EquityPandit
Marksans Pharma, has received Establishment Inspection Report(EIR), for its Goa facility from the US health regulator.
In a BSE filing Marksans Pharma stated that, the company has received EIR from USFDA, after inspection of its Goa facility from April 3-7,2017.
According to USFDA, an EIR is issued to a company after the completion of inspection for a facility.
